Details for Patent: 8,597,272
✉ Email this page to a colleague
Which drugs does patent 8,597,272 protect, and when does it expire?
Patent 8,597,272 protects ZECUITY and is included in one NDA.
This patent has sixteen patent family members in eleven countries.
Summary for Patent: 8,597,272
Title: | Pharmacokinetics of iontophoretic sumatriptan administration |
Abstract: | Improved pharmacokinetic profiles for the iontophoretic delivery of sumatriptan are described. |
Inventor(s): | Sebree; Terri B. (Gladwyne, PA), Pierce; Mark (Essex, CT), O'Neill; Carol (Phoenixville, PA) |
Assignee: | Nupathe, Inc. (Malvern, PA) |
Application Number: | 13/407,434 |
Patent Claim Types: see list of patent claims | Use; Formulation; Delivery; |
Drugs Protected by US Patent 8,597,272
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Branded Pharm | ZECUITY | sumatriptan succinate | SYSTEM;IONTOPHORESIS | 202278-001 | Jan 17, 2013 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,597,272
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2008358027 | ⤷ Try a Trial | |||
Australia | 2015238858 | ⤷ Try a Trial | |||
Canada | 2727927 | ⤷ Try a Trial | |||
Eurasian Patent Organization | 025505 | ⤷ Try a Trial | |||
Eurasian Patent Organization | 201100056 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |